论文部分内容阅读
目的:探究妊娠期不足12周妇女选择米非司酮和米索前列醇联合使用终止妊娠的效果。方法:选取2013年2月-2014年4月收治的92例妊娠期不足12周的妇女采取终止妊娠的措施,随机分组,实验组51例患者给予米非司酮和米索前列醇的综合使用,对照组41例患者使用米非司酮的常规治疗,对比患者的使用效果。结果:实验组患者的流产成功率为94.12%,对照组患者的流产成功率为78.05%。两组患者流产成功率的差异较为显著,有统计学意义(P<0.05)。结论:妊娠12周以内的女性采用米非司酮和米索前列醇的综合使用,可使患者得到安全、彻底的流产,不良反应较少,效果显著。
OBJECTIVE: To investigate the effect of females choosing pregnancy with mifepristone and misoprostol in less than 12 weeks gestation. METHODS: Ninety-two women with gestational age less than 12 weeks admitted from February 2013 to April 2014 were enrolled in this study. Twenty-five pregnant women were randomly divided into groups and 51 patients in the experimental group were given mifepristone and misoprostol In the control group, 41 patients received routine treatment with mifepristone, comparing the effect of the patients. Results: The success rate of abortion was 94.12% in the experimental group and 78.05% in the control group. The differences in the success rate of abortion between the two groups were statistically significant (P <0.05). Conclusions: The combined use of mifepristone and misoprostol for women within 12 weeks of gestation can result in safe and thorough abortion, with fewer side effects and significant effects.